{"parse":{"title":"Epidemiology of metabolic syndrome","pageid":36738647,"revid":854164149,"text":{"*":"<div class=\"mw-parser-output\"><p>This article provides a global overview of the current trends and distribution of <a href=\"/wiki/Metabolic_syndrome\" title=\"Metabolic syndrome\">metabolic syndrome</a>.  Metabolic syndrome (also known as the cardiometabolic syndrome) refers to a cluster of related risk factors for cardiovascular disease that includes abdominal <a href=\"/wiki/Obesity\" title=\"Obesity\">obesity</a>, <a href=\"/wiki/Diabetes\" class=\"mw-redirect\" title=\"Diabetes\">diabetes</a>, <a href=\"/wiki/Hypertension\" title=\"Hypertension\">hypertension</a>, and elevated <a href=\"/wiki/Cholesterol\" title=\"Cholesterol\">cholesterol</a>.<sup id=\"cite_ref-Ford_ES_1-0\" class=\"reference\"><a href=\"#cite_note-Ford_ES-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Ford_ES_et_al_2-0\" class=\"reference\"><a href=\"#cite_note-Ford_ES_et_al-2\">&#91;2&#93;</a></sup>\n</p><p>Data from the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a> suggests 65% of the world's population live in countries where <a href=\"/wiki/Overweight\" title=\"Overweight\">overweight</a> and obesity kills more people than underweight.<sup id=\"cite_ref-O&amp;O_3-0\" class=\"reference\"><a href=\"#cite_note-O&amp;O-3\">&#91;3&#93;</a></sup> The WHO defines \u201coverweight\u201d as a BMI greater than or equal to 25, and \u201cobesity\u201d as a BMI greater than or equal to 30.<sup id=\"cite_ref-O&amp;O_3-1\" class=\"reference\"><a href=\"#cite_note-O&amp;O-3\">&#91;3&#93;</a></sup> Both overweight and obesity are major risk factors for <a href=\"/wiki/Cardiovascular_disease\" title=\"Cardiovascular disease\">cardiovascular diseases</a>, specifically heart disease and stroke, and diabetes.\n</p><p>The <a href=\"/wiki/International_Diabetes_Federation\" title=\"International Diabetes Federation\">International Diabetes Federation</a> reports that as of 2011, 366 million people suffer from diabetes; this number is projected to increase to over half a billion (estimated 552 million) by 2030.<sup id=\"cite_ref-TGB_4-0\" class=\"reference\"><a href=\"#cite_note-TGB-4\">&#91;4&#93;</a></sup> 80 percent of people with diabetes live in <a href=\"/wiki/Developing_countries\" class=\"mw-redirect\" title=\"Developing countries\">developing countries</a> and in 2011, diabetes caused 4.6 million deaths and approximately 78,000 children were diagnosed with <a href=\"/wiki/Type_1_diabetes\" class=\"mw-redirect\" title=\"Type 1 diabetes\">type 1 diabetes</a>.<sup id=\"cite_ref-TGB_4-1\" class=\"reference\"><a href=\"#cite_note-TGB-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Background\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Background</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Africa\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Africa</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Europe\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Europe</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Middle_East_and_North_Africa\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Middle East and North Africa</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#North_America_and_the_Caribbean\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">North America and the Caribbean</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#United_States\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">United States</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#United_states_children\"><span class=\"tocnumber\">5.2</span> <span class=\"toctext\">United states children</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Native_Americans_(American_Indians)\"><span class=\"tocnumber\">5.3</span> <span class=\"toctext\">Native Americans (American Indians)</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#South_and_Central_America\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">South and Central America</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#South-East_Asia\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">South-East Asia</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#Western_Pacific\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">Western Pacific</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#References\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Background\">Background</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=1\" title=\"Edit section: Background\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"note\" class=\"hatnote navigation-not-searchable\">Main article: <a href=\"/wiki/Metabolic_syndrome\" title=\"Metabolic syndrome\">metabolic syndrome</a></div>\n<p>Different definitions of the cardiometabolic syndrome have been proposed by different public health organizations, but recently the International Diabetes Federation (IDF), the <a href=\"/wiki/National_Heart,_Lung,_and_Blood_Institute\" title=\"National Heart, Lung, and Blood Institute\">National Heart, Lung, and Blood Institute</a> (NHLBI), the <a href=\"/wiki/American_Heart_Association\" title=\"American Heart Association\">American Heart Association</a> (AHA), and others proposed a definition for diagnosing the cardiometabolic syndrome that includes the presence of 3 out of the following 5 risk factors:<sup id=\"cite_ref-Ford_ES_1-1\" class=\"reference\"><a href=\"#cite_note-Ford_ES-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Ford_ES_et_al_2-1\" class=\"reference\"><a href=\"#cite_note-Ford_ES_et_al-2\">&#91;2&#93;</a></sup>\n</p>\n<ul><li>Fasting <a href=\"/wiki/Plasma_glucose\" class=\"mw-redirect\" title=\"Plasma glucose\">plasma glucose</a> greater than or equal to 100&#160;mg/dL, or undergoing drug treatment for elevated glucose</li>\n<li><a href=\"/wiki/HDL_cholesterol\" class=\"mw-redirect\" title=\"HDL cholesterol\">HDL cholesterol</a> less than 40&#160;mg/dL in men or less than 50&#160;mg/dL in women, or undergoing drug treatment for reduced HDL cholesterol</li>\n<li><a href=\"/wiki/Triglyceride\" title=\"Triglyceride\">Triglycerides</a> greater than or equal to 150&#160;mg/dL, or undergoing drug treatment for elevated triglycerides</li>\n<li>Waist circumference greater than or equal to 102&#160;cm in men or 88&#160;cm in women (in the United States)</li>\n<li>Blood pressure greater than or equal to 130&#160;mm Hg systolic or 85&#160;mm Hg <a href=\"/wiki/Diastolic\" class=\"mw-redirect\" title=\"Diastolic\">diastolic</a>, or undergoing drug treatment for hypertension</li></ul>\n<p>Approximately 20 \u2013 25 percent of the world\u2019s adult population has the cluster of risk factors that is metabolic syndrome.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>  In 2000, approximately 32% of U.S. adults had the metabolic syndrome.<sup id=\"cite_ref-Ford_ES_1-2\" class=\"reference\"><a href=\"#cite_note-Ford_ES-1\">&#91;1&#93;</a></sup> In more recent years that figure has climbed to 34%.<sup id=\"cite_ref-Ford_ES_et_al_2-2\" class=\"reference\"><a href=\"#cite_note-Ford_ES_et_al-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p><p>People with the cardiometabolic syndrome have twice the likelihood of developing and dying from cardiovascular disease, and more than seven times the risk of developing diabetes, compared to those with no cardiometabolic risk factors.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-Ford_Metabolic_10-0\" class=\"reference\"><a href=\"#cite_note-Ford_Metabolic-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Africa\">Africa</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=2\" title=\"Edit section: Africa\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Diabetes now affects over 14 million people in the central and southern regions of Africa; this number is expected to increase to 28 million people by 2030, according to the IDF Africa.<sup id=\"cite_ref-IDF_A_30_11-0\" class=\"reference\"><a href=\"#cite_note-IDF_A_30-11\">&#91;11&#93;</a></sup> The NGO Project Hope cites lifestyle changes as the primary cause of the increase of diabetes, specifically type 2 diabetes, which seems to correspond with a growing waist line.  Lack of physical activity, increased consumption of processed food and unmanaged portion sizes all contribute to the rise of diabetes \u2013 a major component of cardiometabolic risk.<sup id=\"cite_ref-VOA_31_12-0\" class=\"reference\"><a href=\"#cite_note-VOA_31-12\">&#91;12&#93;</a></sup> In countries where there are food crises, \u201cmuch of the foods donated from the international community are calorie-dense foods\u201d,<sup id=\"cite_ref-VOA_31_12-1\" class=\"reference\"><a href=\"#cite_note-VOA_31-12\">&#91;12&#93;</a></sup> according to Project Hope\u2019s Senior Advisor, Paul Madden.  Nutrition education is essential to prevent type 2 diabetes from consuming the continent. The NGO also suggests that in some villages, 70 to 80 percent of the people may not even be aware that they are living with the disease.<sup id=\"cite_ref-VOA_31_12-2\" class=\"reference\"><a href=\"#cite_note-VOA_31-12\">&#91;12&#93;</a></sup>\n</p><p>Studies published in the Indian Journal of Endocrinology and Metabolism focused on the prevalence of metabolic syndrome and its components in different African populations using various criteria. Reports from <a href=\"/wiki/Lagos,_Nigeria\" class=\"mw-redirect\" title=\"Lagos, Nigeria\">Lagos, Nigeria</a>, for instance, showed the prevalence rate of metabolic syndrome as high as over 80% among diabetic patients.<sup id=\"cite_ref-Okafor_32_13-0\" class=\"reference\"><a href=\"#cite_note-Okafor_32-13\">&#91;13&#93;</a></sup> The current trend of rising metabolic syndrome in African populations is largely and generally attributed to \u201cadoption of western lifestyle which is characterized by reduced physical activity, substitution of the traditional African diet rich in fruits, and vegetables for the more energy-laden foods\u201d.<sup id=\"cite_ref-Okafor_32_13-1\" class=\"reference\"><a href=\"#cite_note-Okafor_32-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Europe\">Europe</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=3\" title=\"Edit section: Europe\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Currently, more than 55 million people in Europe have been diagnosed with diabetes, according to the IDF; by 2030 this total will rise to 64 million people.<sup id=\"cite_ref-IDF_33_14-0\" class=\"reference\"><a href=\"#cite_note-IDF_33-14\">&#91;14&#93;</a></sup> Roughly 8.4% of adults are suffering from the effects of this disease, which caused 622,114 deaths in the region this year.33  IDF studies have also concluded that Europe has the highest number of children with <a href=\"/wiki/Type_1_diabetes\" class=\"mw-redirect\" title=\"Type 1 diabetes\">type 1 diabetes</a>.<sup id=\"cite_ref-IDF_33_14-1\" class=\"reference\"><a href=\"#cite_note-IDF_33-14\">&#91;14&#93;</a></sup>\n</p><p>The European Global Cardiometabolic Risk Profile in Patients with Hypertension Disease (GOOD) survey investigated the cardiometabolic risk profile in adult patients with hypertension across 289 locations in four European regions.  Across the Northwest, Mediterranean, Atlantic European Mainland and Central Europe zones, demographic, lifestyle, clinical and laboratory data were collected from eligible patients during one clinic visit.<sup id=\"cite_ref-GOOD_34_15-0\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup>\nIn <a href=\"/wiki/Central_Europe\" title=\"Central Europe\">Central Europe</a> 44% of the participants had type 2 diabetes compared with 33% in the Atlantic European Mainland, and 26% in the Northwest and the Mediterranean regions.<sup id=\"cite_ref-GOOD_34_15-1\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup> The study revealed a prevalence of metabolic syndrome affected 68% of Central Europe, 60% of the Atlantic European Mainland, 52% of the Mediterranean regions and 50% of Northwest Europe.<sup id=\"cite_ref-GOOD_34_15-2\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup> Fasting blood glucose, total cholesterol and triglyceride levels were all highest in Central Europe compared with the other three regions.<sup id=\"cite_ref-GOOD_34_15-3\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup> Roughly 80% of the Atlantic European Mainland patients had uncontrolled blood pressure, whereas the other three regions tallied approximately 70-71%.<sup id=\"cite_ref-GOOD_34_15-4\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup> Compared to the Northwest, Mediterranean, and Central Europe regions, declared alcohol consumption was also recorded the highest in the Atlantic European Mainland; exercise was lowest in Central Europe.<sup id=\"cite_ref-GOOD_34_15-5\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup>\n</p><p>The GOOD survey recorded cases of <a href=\"/wiki/Congestive_heart_failure\" class=\"mw-redirect\" title=\"Congestive heart failure\">congestive heart failure</a>, left <a href=\"/wiki/Ventricular_hypertrophy\" title=\"Ventricular hypertrophy\">ventricular hypertrophy</a>, <a href=\"/wiki/Coronary_artery_disease\" title=\"Coronary artery disease\">coronary artery disease</a> and stable/unstable <a href=\"/wiki/Angina\" title=\"Angina\">angina</a> were highest in Central Europe compared with the other regions.<sup id=\"cite_ref-GOOD_34_15-6\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup>  Family history of premature stroke or <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">myocardial infarction</a>, stroke, <a href=\"/w/index.php?title=Coronary_revascularization&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Coronary revascularization (page does not exist)\">coronary revascularization</a> and transient <a href=\"/w/index.php?title=Ischaemic_attack&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Ischaemic attack (page does not exist)\">ischaemic attacks</a> had the highest prevalence in the Atlantic European Mainland.<sup id=\"cite_ref-GOOD_34_15-7\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup>  Statistical conclusions indicate that hypertensive patients across Europe exhibit multiple cardiometabolic risk factors, with greater predominance in Central Europe and the Atlantic European Mainland compared with Northwest and Mediterranean regions.<sup id=\"cite_ref-GOOD_34_15-8\" class=\"reference\"><a href=\"#cite_note-GOOD_34-15\">&#91;15&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Middle_East_and_North_Africa\">Middle East and North Africa</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=4\" title=\"Edit section: Middle East and North Africa\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The International Diabetes Federation reports more than 34.2 million people in the Middle East and North Africa have diabetes; this number will rise to 59.7 million by the year 2030 unless counteractive measures are introduced.<sup id=\"cite_ref-MENA_35_16-0\" class=\"reference\"><a href=\"#cite_note-MENA_35-16\">&#91;16&#93;</a></sup>  In 2012, diabetes caused 356,586 deaths in this region, a zone with the highest prevalence of diabetes in adults (11%) in the world.<sup id=\"cite_ref-MENA_35_16-1\" class=\"reference\"><a href=\"#cite_note-MENA_35-16\">&#91;16&#93;</a></sup>\n</p><p>Turkey reported a prevalence of 33.9% for metabolic syndrome (MS), with a higher prevalence in women (39.6%) than in men (28%).<sup id=\"cite_ref-MSME_36_17-0\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> The survey included random samples from both urban and rural populations in seven geographical regions of Turkey.  More than one-third (35.08%) of the participants were obese.<sup id=\"cite_ref-MSME_36_17-1\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> Of those tested, 13.66% had hypertension, while those with diabetes mellitus (DM) and MS were 4.16% and 17.91%, respectively.<sup id=\"cite_ref-MSME_36_17-2\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> The frequency of hypertension, MS and obesity were higher in females than males; however, DM was higher in males than females.<sup id=\"cite_ref-MSME_36_17-3\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> According to the IDF, metabolic syndrome was prevalent in 16.1% of the Saudi Arabian population.<sup id=\"cite_ref-MSME_36_17-4\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> In Tunisia, metabolic syndrome incidence was 45.5% based on the IDF criteria.<sup id=\"cite_ref-MSME_36_17-5\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> 37.4% of Iranians aging from 25-64, living in both urban and rural areas of all 30 provinces in Iran, had MS (based on the IDF definition); results based on the Adult Treatment Panel III (ATPIII)/American Heart Association (AHA)/National Heart, Lung, and Blood Institute (NHLBI) standards suggest 41.6% of the same group of Iranians suffer from metabolic syndrome.<sup id=\"cite_ref-MSME_36_17-6\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup> The affliction of the MS is estimated to affect more than 11 million Iranians.<sup id=\"cite_ref-MSME_36_17-7\" class=\"reference\"><a href=\"#cite_note-MSME_36-17\">&#91;17&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"North_America_and_the_Caribbean\">North America and the Caribbean</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=5\" title=\"Edit section: North America and the Caribbean\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Current IDF data proposes more than 38.4 million people in North American and the Caribbean have diabetes and projects this number will increase to 51.2 million by 2030.<sup id=\"cite_ref-NAC_37_18-0\" class=\"reference\"><a href=\"#cite_note-NAC_37-18\">&#91;18&#93;</a></sup> In 2012, 11% of (or approximately 4.2 million) adults in the NAC Region endured the disease; this year, diabetes was responsible for 287,020 deaths in North America.<sup id=\"cite_ref-NAC_37_18-1\" class=\"reference\"><a href=\"#cite_note-NAC_37-18\">&#91;18&#93;</a></sup>\n</p><p>The National Center for Biotechnological Information notes the incidence of the metabolic syndrome among Caribbean-born persons in the U. S. Virgin Islands is comparable to that among the population on the mainland of the United States. The groups involved in the study were Hispanic white, Hispanic black, non-Hispanic black born in the U.S. Virgin Islands, and non-Hispanic black born elsewhere in the Caribbean.<sup id=\"cite_ref-MS_Caribbean_38_19-0\" class=\"reference\"><a href=\"#cite_note-MS_Caribbean_38-19\">&#91;19&#93;</a></sup>  Hispanic ethnicity was independently associated with an increased risk of having the metabolic syndrome, high triglycerides, and low high density lipoprotein cholesterol levels.<sup id=\"cite_ref-MS_Caribbean_38_19-1\" class=\"reference\"><a href=\"#cite_note-MS_Caribbean_38-19\">&#91;19&#93;</a></sup> Among Caribbean-born persons living in the U.S. Virgin Islands, those who are Hispanic blacks may have a greater risk of cardiovascular disease than do other groups.<sup id=\"cite_ref-MS_Caribbean_38_19-2\" class=\"reference\"><a href=\"#cite_note-MS_Caribbean_38-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"United_States\">United States</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=6\" title=\"Edit section: United States\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Approximately 27 million Americans, or nearly 11% of the population, have diabetes, according to the American Diabetes Association and the <a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">Centers for Disease Control and Prevention</a>.<sup id=\"cite_ref-CDC_20-0\" class=\"reference\"><a href=\"#cite_note-CDC-20\">&#91;20&#93;</a></sup> By 2050, the <a href=\"/wiki/Prevalence\" title=\"Prevalence\">prevalence</a> of diabetes could increase to as much as 33% of the population, largely due to the aging of the population and to people with diabetes living longer.<sup id=\"cite_ref-Boyle_21-0\" class=\"reference\"><a href=\"#cite_note-Boyle-21\">&#91;21&#93;</a></sup> Approximately 1.9 million new cases of diabetes are diagnosed each year. The disease was the seventh leading cause of death in 2007, directly claiming more than 71,000 lives and contributing to approximately 160,000 additional deaths.<sup id=\"cite_ref-CDC_20-1\" class=\"reference\"><a href=\"#cite_note-CDC-20\">&#91;20&#93;</a></sup> Patients with diabetes are two to four times more likely than those without it to die from cardiovascular disease, and diabetes is an important cause of blindness, kidney disease, and lower-extremity amputations.<sup id=\"cite_ref-CDC_20-2\" class=\"reference\"><a href=\"#cite_note-CDC-20\">&#91;20&#93;</a></sup>\n</p><p>An additional 79 million Americans have <a href=\"/wiki/Prediabetes\" title=\"Prediabetes\">prediabetes</a>.<sup id=\"cite_ref-CDC_20-3\" class=\"reference\"><a href=\"#cite_note-CDC-20\">&#91;20&#93;</a></sup> Individuals with prediabetes have <a href=\"/wiki/Blood_glucose\" class=\"mw-redirect\" title=\"Blood glucose\">blood glucose</a> levels that are higher than normal but not high enough to be classified as diabetes.<sup id=\"cite_ref-Mayo_22-0\" class=\"reference\"><a href=\"#cite_note-Mayo-22\">&#91;22&#93;</a></sup> Without intervention, most people with prediabetes will develop diabetes within ten years.<sup id=\"cite_ref-NIDDKD_23-0\" class=\"reference\"><a href=\"#cite_note-NIDDKD-23\">&#91;23&#93;</a></sup> In addition, studies have shown that these individuals are at increased risk for cardiovascular disease, including a heart attack or stroke.<sup id=\"cite_ref-DeFronzo_24-0\" class=\"reference\"><a href=\"#cite_note-DeFronzo-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-Pour_25-0\" class=\"reference\"><a href=\"#cite_note-Pour-25\">&#91;25&#93;</a></sup><sup id=\"cite_ref-Ford_Pre_26-0\" class=\"reference\"><a href=\"#cite_note-Ford_Pre-26\">&#91;26&#93;</a></sup> Individuals with prediabetes are also likely to have additional cardiovascular risk factors such as elevated cholesterol and high blood pressure.<sup id=\"cite_ref-DeFronzo_24-1\" class=\"reference\"><a href=\"#cite_note-DeFronzo-24\">&#91;24&#93;</a></sup>\n</p><p>Diabetes and prediabetes are strongly linked to obesity and overweight.<sup id=\"cite_ref-TOS_27-0\" class=\"reference\"><a href=\"#cite_note-TOS-27\">&#91;27&#93;</a></sup> Nearly 50% of people with diabetes are obese, and 90% are overweight.<sup id=\"cite_ref-TOS_27-1\" class=\"reference\"><a href=\"#cite_note-TOS-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-ADA_Dia_Bas_28-0\" class=\"reference\"><a href=\"#cite_note-ADA_Dia_Bas-28\">&#91;28&#93;</a></sup> 19 A chief risk factor for prediabetes is excess abdominal fat.<sup id=\"cite_ref-Mayo_22-1\" class=\"reference\"><a href=\"#cite_note-Mayo-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-NIDDKD_23-1\" class=\"reference\"><a href=\"#cite_note-NIDDKD-23\">&#91;23&#93;</a></sup> Obesity increases one\u2019s risk for a variety of other medical problems, including hypertension, stroke, other forms of cardiovascular disease, <a href=\"/wiki/Arthritis\" title=\"Arthritis\">arthritis</a>, and several forms of <a href=\"/wiki/Cancer\" title=\"Cancer\">cancer</a>.<sup id=\"cite_ref-WHOO&amp;O_29-0\" class=\"reference\"><a href=\"#cite_note-WHOO&amp;O-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-CDCO&amp;O_30-0\" class=\"reference\"><a href=\"#cite_note-CDCO&amp;O-30\">&#91;30&#93;</a></sup> Obese individuals are at twice the risk of dying from any cause than normal-weight individuals.<sup id=\"cite_ref-Roger_VL_31-0\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> The prevalence of obesity and overweight have risen to epidemic proportions in the United States, where 67% of adults are overweight and, of these, approximately half are obese.<sup id=\"cite_ref-CDCO&amp;O_30-1\" class=\"reference\"><a href=\"#cite_note-CDCO&amp;O-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-Roger_VL_31-1\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup>\n</p><p>The prevalence of hypertension, another cardiometabolic syndrome component, has been increasing for the last decade. In 1994, 24% of U.S. adults had hypertension. Today, that figure has risen to 29%, according to data from the National Health and Nutrition Examination Survey.<sup id=\"cite_ref-Roger_VL_31-2\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup><sup id=\"cite_ref-Yoon_32-0\" class=\"reference\"><a href=\"#cite_note-Yoon-32\">&#91;32&#93;</a></sup> In addition, nearly 30% of U.S. adults have prehypertension.<sup id=\"cite_ref-Roger_VL_31-3\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> Hypertension increases one\u2019s risk of suffering a stroke, developing end-stage renal disease, and dying from cardiovascular disease. In recent years, hypertension has directly claimed more than 61,000 U.S. lives and has contributed to approximately 347,000 deaths each year.<sup id=\"cite_ref-Roger_VL_31-4\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup>\n</p><p>Of the components of the cardiometabolic syndrome, only the prevalence of <a href=\"/wiki/Dyslipidemia\" title=\"Dyslipidemia\">dyslipidemia</a> has declined in the United States. Between 1999 and 2010, the percentage of U.S. adults with high total cholesterol declined from approximately 18% to 13%.<sup id=\"cite_ref-CDCP_CFS_33-0\" class=\"reference\"><a href=\"#cite_note-CDCP_CFS-33\">&#91;33&#93;</a></sup> However, according to the <a href=\"/wiki/American_Heart_Association\" title=\"American Heart Association\">American Heart Association</a>, nearly half of U.S. adults today (44%) are still at increased risk for atherosclerotic disease because their levels of total cholesterol are elevated (200&#160;mg/dL or higher).<sup id=\"cite_ref-Roger_VL_31-5\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> Of these 98.8 million individuals with elevated cholesterol, 33.6 million have high cholesterol (240&#160;mg/dL or above), and 71.3 million have low-density lipoprotein (LDL) cholesterol levels of 130&#160;mg/dL or higher.<sup id=\"cite_ref-Roger_VL_31-6\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> In addition, approximately 19% of U.S. adults have low levels of high-density lipoprotein (HDL) cholesterol,<sup id=\"cite_ref-Ford_Metabolic_10-1\" class=\"reference\"><a href=\"#cite_note-Ford_Metabolic-10\">&#91;10&#93;</a></sup> and one-third have elevated triglycerides.<sup id=\"cite_ref-Cohen_JD_25_34-0\" class=\"reference\"><a href=\"#cite_note-Cohen_JD_25-34\">&#91;34&#93;</a></sup> Finally, dyslipidemia affects the vast majority (up to 97%) of individuals with diabetes and contributes to their elevated risk for cardiovascular disease.<sup id=\"cite_ref-ADADD_26_35-0\" class=\"reference\"><a href=\"#cite_note-ADADD_26-35\">&#91;35&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"United_states_children\">United states children</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=7\" title=\"Edit section: United states children\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>According to estimates from the American Heart Association, more than 9% of U.S. children and adolescents aged 12\u201319, or nearly three million individuals, have the metabolic syndrome.<sup id=\"cite_ref-Roger_VL_31-7\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> Among overweight and obese adolescents, this prevalence rate rises to 44%. Two-thirds of adolescents have at least one metabolic abnormality.<sup id=\"cite_ref-Roger_VL_31-8\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup>\n</p><p>Preliminary prospective studies report that children and adolescents with the metabolic syndrome are at high risk of developing cardiovascular disease and diabetes as adults. One 25-year prospective study found that, compared with children without the syndrome, those with the metabolic syndrome are 14 times more likely to suffer from cardiovascular disease and 11 times more likely to develop diabetes when they reach adulthood.<sup id=\"cite_ref-Schubert_27_36-0\" class=\"reference\"><a href=\"#cite_note-Schubert_27-36\">&#91;36&#93;</a></sup>\nCardiometabolic risk among children and adolescents is fueled by the rising prevalence of obesity in this age group. From 1980 to 2008, rates of obesity have increased from 5% to 10% among preschool children aged 2\u20135. During the same time period, obesity increased from 6.5% to nearly 20% among 6-11year-olds and from 5% to 18% among adolescents aged 12\u201319.<sup id=\"cite_ref-CDC_28_37-0\" class=\"reference\"><a href=\"#cite_note-CDC_28-37\">&#91;37&#93;</a></sup> Hypertension among children and adolescents has increased by 1% since 1999 and is estimated to affect 3.6% of those aged 3\u201318.<sup id=\"cite_ref-Roger_VL_31-9\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> This increase is attributed to the rising number of overweight and obese children.<sup id=\"cite_ref-Roger_VL_31-10\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> The prevalence of lipid abnormalities among children and adolescents is also tied to obesity and overweight. Approximately 14% of normal-weight youths aged 12\u201319 have lipid abnormalities.<sup id=\"cite_ref-Roger_VL_31-11\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup> That figure rises to 22% of overweight youths and nearly 43% of obese youths.<sup id=\"cite_ref-Roger_VL_31-12\" class=\"reference\"><a href=\"#cite_note-Roger_VL-31\">&#91;31&#93;</a></sup>\n</p><p>Obesity is also tied to the rise of type 2 diabetes among U.S. children. Until recently, diabetes in children was typically assumed to be type 1, formerly known as juvenile-onset diabetes.<sup id=\"cite_ref-CDC_29_38-0\" class=\"reference\"><a href=\"#cite_note-CDC_29-38\">&#91;38&#93;</a></sup> However, according to the Centers for Disease Control and Prevention, recent clinical evidence indicates that the prevalence of type 2 diabetes, formerly known as adult-onset diabetes, is increasing among American children and adolescents.<sup id=\"cite_ref-CDC_29_38-1\" class=\"reference\"><a href=\"#cite_note-CDC_29-38\">&#91;38&#93;</a></sup> This increase is most notable among Blacks, Asian/Pacific Islanders, Hispanics, and American Indians. Children who develop type 2 diabetes are typically overweight or obese. \u201cType 2 diabetes in children and adolescents already appears to be a sizable and growing problem,\u201d the CDC says. \u201cBetter physician awareness and monitoring of the disease\u2019s magnitude will be necessary.\u201d<sup id=\"cite_ref-CDC_29_38-2\" class=\"reference\"><a href=\"#cite_note-CDC_29-38\">&#91;38&#93;</a></sup>\n</p>\n<h3><span id=\"Native_Americans_.28American_Indians.29\"></span><span class=\"mw-headline\" id=\"Native_Americans_(American_Indians)\">Native Americans (American Indians)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=8\" title=\"Edit section: Native Americans (American Indians)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The National Cholesterol Education Program compiled and presented data from the Indian Health Service that indicates increasing mortality rates due to cardiovascular disease vary among American Indian communities.  The significant independent predictors of CVD in Native American women were diabetes, age, obesity, LDL, albuminuria, triglycerides, and hypertension.<sup id=\"cite_ref-NCEP_39_39-0\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> In men the significant predictors of CVD were diabetes, age, LDL, albuminuria, and hypertension.<sup id=\"cite_ref-NCEP_39_39-1\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> Unlike other ethnic groups, Native Americans appear to have an increasing frequency of coronary heart disease, possibly related to the high and increasing prevalence of diabetes in these communities.<sup id=\"cite_ref-NCEP_39_39-2\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> Although total and LDL-cholesterol levels are lower than the U.S. average, importance of LDL cholesterol as a contributor to CHD in this group should not be underestimated. Moreover, because of the high frequency of type 2 diabetes, many Native Americans will have an even lower LDL goal.<sup id=\"cite_ref-NCEP_39_39-3\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup>  The evidence for differences in baseline risk between Native American and white populations is not strong enough to justify separate guidelines for Native American populations.\n</p>\n<h2><span class=\"mw-headline\" id=\"South_and_Central_America\">South and Central America</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=9\" title=\"Edit section: South and Central America\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The IDF reports 9.2% of adults in the South and Central America have diabetes and 12.3% of deaths in adults in the SACA Region can be attributed to the disease.<sup id=\"cite_ref-SACA_40_40-0\" class=\"reference\"><a href=\"#cite_note-SACA_40-40\">&#91;40&#93;</a></sup> More than 26.4 million people in the SACA Region have diabetes; by 2030 this will rise to 39.9 million.<sup id=\"cite_ref-SACA_40_40-1\" class=\"reference\"><a href=\"#cite_note-SACA_40-40\">&#91;40&#93;</a></sup> Approximately 236,328 disease related fatalities occurred in the SACA Region in 2012.<sup id=\"cite_ref-SACA_40_40-2\" class=\"reference\"><a href=\"#cite_note-SACA_40-40\">&#91;40&#93;</a></sup>\n</p><p>The Latin American populations exhibit a high prevalence of abdominal obesity and metabolic syndrome, similar or even higher than developed countries. It is attributed to changes in their lifestyle, migration from rural to urban areas and a higher susceptibility to accumulate abdominal fat and develop more insulin resistance compared to other ethnically different populations.<sup id=\"cite_ref-EMSLA_41_41-0\" class=\"reference\"><a href=\"#cite_note-EMSLA_41-41\">&#91;41&#93;</a></sup> Some genetic factors and metabolic adaptations during fetal life can be claimed as etiological factors of this condition.<sup id=\"cite_ref-EMSLA_41_41-1\" class=\"reference\"><a href=\"#cite_note-EMSLA_41-41\">&#91;41&#93;</a></sup>\n</p><p>Although cardiovascular disease (CVD) is the leading cause of death and disability in the majority of the countries in Latin America, few data about regional differences on this topic has emerged.<sup id=\"cite_ref-EHSA_42_42-0\" class=\"reference\"><a href=\"#cite_note-EHSA_42-42\">&#91;42&#93;</a></sup> Developing countries have scarce epidemiological data on cardiovascular (CV) risk factor prevalence, which only allows for limited control and treatment options.<sup id=\"cite_ref-SEA_43_43-0\" class=\"reference\"><a href=\"#cite_note-SEA_43-43\">&#91;43&#93;</a></sup> The load of the CV risk factors, especially hypertension, remains uncertain.\n</p>\n<h2><span class=\"mw-headline\" id=\"South-East_Asia\">South-East Asia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=10\" title=\"Edit section: South-East Asia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A 2012 IDF South-East Asia report states one fifth of all adults living with diabetes live in South East Asia and 8.7% of adults in the region endure the disease, according to the International Diabetes Federation.<sup id=\"cite_ref-SEA_43_43-1\" class=\"reference\"><a href=\"#cite_note-SEA_43-43\">&#91;43&#93;</a></sup> As of this 2012, 70.3 million people in the SEA Region have diabetes; by 2030 this will rise to 120.9 million diagnoses.<sup id=\"cite_ref-SEA_43_43-2\" class=\"reference\"><a href=\"#cite_note-SEA_43-43\">&#91;43&#93;</a></sup>\n</p><p>There has been special interest in South Asians because they have been reported to have very high frequency rates of coronary heart disease at younger ages in the absence of traditional risk factors.  The higher CHD risk in this population may be related in part to a higher prevalence of insulin resistance, the metabolic syndrome, and diabetes.<sup id=\"cite_ref-NCEP_39_39-4\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> Lipoprotein levels have also been reported to be elevated, elevating the importance of initiating remedies to reduce cholesterol and other CHD risk factors in this group with South Asian Indian ancestry.<sup id=\"cite_ref-NCEP_39_39-5\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup>  A growing body of evidence indicates that South Asians are at high baseline risk for CHD, compared to American whites; they are particularly at risk for the metabolic syndrome and type 2 diabetes.<sup id=\"cite_ref-NCEP_39_39-6\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> Also, increased emphasis should be given to life habit changes to mitigate the metabolic syndrome in this population.<sup id=\"cite_ref-NCEP_39_39-7\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> All other data reflects cholesterol management guidelines should remain the same for the SEA population as well as for other population groups.\n</p>\n<h2><span class=\"mw-headline\" id=\"Western_Pacific\">Western Pacific</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=11\" title=\"Edit section: Western Pacific\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The IDF Western pacific reports more people with diabetes live in the Western Pacific than any other region in the world.<sup id=\"cite_ref-WP_44_44-0\" class=\"reference\"><a href=\"#cite_note-WP_44-44\">&#91;44&#93;</a></sup> Approximately 132.2 million people in the WP Region have diabetes; if proper precautions are not utilized, this number is projected to escalate to 187.9 million people by 2030. 44 8% of all Western Pacific adults have diabetes and in 2012, the illness caused 1.7 million deaths in the Western Pacific.<sup id=\"cite_ref-WP_44_44-1\" class=\"reference\"><a href=\"#cite_note-WP_44-44\">&#91;44&#93;</a></sup>\n</p><p>There is limited information on the risks and benefits of lipid management for reduction of coronary heart disease (CHD) and cardiovascular disease (CVD) in this population.<sup id=\"cite_ref-NCEP_39_39-8\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> In the Honolulu Heart Program report, CHD and CVD mortality rates are lower than in the general U.S. population.<sup id=\"cite_ref-NCEP_39_39-9\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup> However, the evidence for differences between Pacific Islander and general U.S. Populations is not strong enough to justify the creating of separate guidelines.<sup id=\"cite_ref-NCEP_39_39-10\" class=\"reference\"><a href=\"#cite_note-NCEP_39-39\">&#91;39&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Epidemiology_of_metabolic_syndrome&amp;action=edit&amp;section=12\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Ford_ES-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ford_ES_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ford_ES_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ford_ES_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ford ES (2010). \"Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the U.S.\". <i>J Diabetes</i>. <b>2</b>: 180\u2013193. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1753-0407.2010.00078.x\">10.1111/j.1753-0407.2010.00078.x</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Diabetes&amp;rft.atitle=Prevalence+and+correlates+of+metabolic+syndrome+based+on+a+harmonious+definition+among+adults+in+the+U.S.&amp;rft.volume=2&amp;rft.pages=180-193&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1753-0407.2010.00078.x&amp;rft.au=Ford+ES&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ford_ES_et_al-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ford_ES_et_al_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ford_ES_et_al_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Ford_ES_et_al_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ford ES;  et al. (2004). \"Increasing prevalence of the metabolic syndrome among U.S. adults\". <i>Diabetes Care</i>. <b>27</b>: 2444\u20132449. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2337/diacare.27.10.2444\">10.2337/diacare.27.10.2444</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Care&amp;rft.atitle=Increasing+prevalence+of+the+metabolic+syndrome+among+U.S.+adults&amp;rft.volume=27&amp;rft.pages=2444-2449&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.27.10.2444&amp;rft.au=Ford+ES&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-O&amp;O-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-O&amp;O_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-O&amp;O_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Obesity and Overweight.\" WHO. N.p., n.d. Web. 28 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.who.int/mediacentre/factsheets/fs311/en/\">http://www.who.int/mediacentre/factsheets/fs311/en/</a>&gt;.</span>\n</li>\n<li id=\"cite_note-TGB-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TGB_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TGB_4-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"The Global Burden.\" International Diabetes Federation. N.p., n.d. Web. 28 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/diabetesatlas/5e/the-global-burden\">http://www.idf.org/diabetesatlas/5e/the-global-burden</a>&gt;.</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">Alberti, George, Paul Zimmet, and Johnathan Shaw. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Publication. Ed. Scott M. Grundy. Brussels, Belgium: International Diabetes Federation, 2006. Web. 29 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf\">http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf</a>&gt;.</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mozumdar A, Liguori G (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3005489\">\"Persistent increase in prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006\"</a>. <i>Diabetes Care</i>. <b>34</b>: 216\u2013219. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2337/dc10-0879\">10.2337/dc10-0879</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3005489\">3005489</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20889854\">20889854</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Care&amp;rft.atitle=Persistent+increase+in+prevalence+of+metabolic+syndrome+among+U.S.+adults%3A+NHANES+III+to+NHANES+1999-2006&amp;rft.volume=34&amp;rft.pages=216-219&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3005489&amp;rft_id=info%3Apmid%2F20889854&amp;rft_id=info%3Adoi%2F10.2337%2Fdc10-0879&amp;rft.aulast=Mozumdar&amp;rft.aufirst=A&amp;rft.au=Liguori%2C+G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3005489&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wilson PWF;  et al. (2005). \"Metabolic syndrome as a precursor of <a href=\"/wiki/Cardiovascular_disease\" title=\"Cardiovascular disease\">cardiovascular disease</a> and <a href=\"/wiki/Type_2_diabetes\" class=\"mw-redirect\" title=\"Type 2 diabetes\">type 2 diabetes</a> mellitus\". <i>Circulation</i>. <b>112</b>: 3066\u20133072. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/circulationaha.105.539528\">10.1161/circulationaha.105.539528</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Metabolic+syndrome+as+a+precursor+of+cardiovascular+disease+and+type+2+diabetes+mellitus&amp;rft.volume=112&amp;rft.pages=3066-3072&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1161%2Fcirculationaha.105.539528&amp;rft.au=Wilson+PWF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Suzuki T;  et al. (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2597726\">\"Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS)\"</a>. <i>Am Heart J</i>. <b>156</b>: 405\u2013410. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ahj.2008.02.022\">10.1016/j.ahj.2008.02.022</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2597726\">2597726</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+Heart+J.&amp;rft.atitle=Metabolic+syndrome%2C+endothelial+dysfunction%2C+and+risk+of+cardiovascular+events%3A+the+Northern+Manhattan+Study+%28NOMAS%29&amp;rft.volume=156&amp;rft.pages=405-410&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2597726&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ahj.2008.02.022&amp;rft.au=Suzuki+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2597726&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Benetos A;  et al. (2008). \"All-cause cardiovascular mortality using different definitions of the metabolic syndrome\". <i>Am J Cardiol</i>. <b>102</b>: 188\u2013191. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjcard.2008.03.037\">10.1016/j.amjcard.2008.03.037</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Cardiol&amp;rft.atitle=All-cause+cardiovascular+mortality+using+different+definitions+of+the+metabolic+syndrome&amp;rft.volume=102&amp;rft.pages=188-191&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjcard.2008.03.037&amp;rft.au=Benetos+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span><span class=\"citation-comment\" style=\"display:none; color:#33aa33; margin-left:0.3em\">CS1 maint: Explicit use of et al. (<a href=\"/wiki/Category:CS1_maint:_Explicit_use_of_et_al.\" title=\"Category:CS1 maint: Explicit use of et al.\">link</a>) </span></span>\n</li>\n<li id=\"cite_note-Ford_Metabolic-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Ford_Metabolic_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Ford_Metabolic_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ford ES;  et al. (2008). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518368\">\"Metabolic syndrome and incident diabetes: current state of the evidence\"</a>. <i>Diabetes Care</i>. <b>31</b>: 1898\u20131904. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2337/dc08-0423\">10.2337/dc08-0423</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518368\">2518368</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18591398\">18591398</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+Care&amp;rft.atitle=Metabolic+syndrome+and+incident+diabetes%3A+current+state+of+the+evidence&amp;rft.volume=31&amp;rft.pages=1898-1904&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2518368&amp;rft_id=info%3Apmid%2F18591398&amp;rft_id=info%3Adoi%2F10.2337%2Fdc08-0423&amp;rft.au=Ford+ES&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2518368&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-IDF_A_30-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-IDF_A_30_11-0\">^</a></b></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 Africa.\" IDF Africa - Diabetes Update Fact Sheet. International Diabetes Federation - IDF Africa, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_AFR_5E_Update_FactSheet_0.pdf\">http://www.idf.org/sites/default/files/IDF_AFR_5E_Update_FactSheet_0.pdf</a>&gt;.</span>\n</li>\n<li id=\"cite_note-VOA_31-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-VOA_31_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-VOA_31_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-VOA_31_12-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Lewis, Kim. \"Diabetes Explodes in Sub-Saharan Africa.\" VOA. N.p., 28 Nov. 2012. Web. 28 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.voanews.com/content/diabetes-sub-saharan-africa-africa-hopeclinic-projecthope/1554338.html\">http://www.voanews.com/content/diabetes-sub-saharan-africa-africa-hopeclinic-projecthope/1554338.html</a>&gt;.</span>\n</li>\n<li id=\"cite_note-Okafor_32-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Okafor_32_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Okafor_32_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Okafor CI (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263198\">\"The metabolic syndrome in Africa: Current trends\"</a>. <i>Indian J Endocrinol Metab</i>. <b>16</b>: 56\u201366. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4103/2230-8210.91191\">10.4103/2230-8210.91191</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263198\">3263198</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22276253\">22276253</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+J+Endocrinol+Metab&amp;rft.atitle=The+metabolic+syndrome+in+Africa%3A+Current+trends&amp;rft.volume=16&amp;rft.pages=56-66&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263198&amp;rft_id=info%3Apmid%2F22276253&amp;rft_id=info%3Adoi%2F10.4103%2F2230-8210.91191&amp;rft.au=Okafor+CI&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263198&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-IDF_33-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-IDF_33_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-IDF_33_14-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 Europe.\" IDF Europe - Diabetes Update Fact Sheet. International Diabetes Federation - IDF Europe, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_EUR_5E_Update_FactSheet1_0.pdf\">http://www.idf.org/sites/default/files/IDF_EUR_5E_Update_FactSheet1_0.pdf</a>&gt;.</span>\n</li>\n<li id=\"cite_note-GOOD_34-15\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-GOOD_34_15-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-GOOD_34_15-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Farsang C, Naditch-Brule L, Perlini S, Zidek W, Kjeldsen SE (2009). \"Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey\". <i>J Hum Hypertens</i>. <b>23</b>: 316\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/jhh.2008.136\">10.1038/jhh.2008.136</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19005476\">19005476</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Hum+Hypertens&amp;rft.atitle=Inter-regional+comparisons+of+the+prevalence+of+cardiometabolic+risk+factors+in+patients+with+hypertension+in+Europe%3A+the+GOOD+survey&amp;rft.volume=23&amp;rft.pages=316-24&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1038%2Fjhh.2008.136&amp;rft_id=info%3Apmid%2F19005476&amp;rft.aulast=Farsang&amp;rft.aufirst=C&amp;rft.au=Naditch-Brule%2C+L&amp;rft.au=Perlini%2C+S&amp;rft.au=Zidek%2C+W&amp;rft.au=Kjeldsen%2C+SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-MENA_35-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MENA_35_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MENA_35_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 Middle East and North Africa.\" IDF MENA - Diabetes Update Fact Sheet. International Diabetes Federation - IDF MENA, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_MENA_5E_Update_FactSheet.pdf\">http://www.idf.org/sites/default/files/IDF_MENA_5E_Update_FactSheet.pdf</a>&gt;.</span>\n</li>\n<li id=\"cite_note-MSME_36-17\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MSME_36_17-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-MSME_36_17-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sliem HA, Ahmed S, Nemr N, El-Sherif I (2012). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263199\">\"Metabolic syndrome in the Middle East\"</a>. <i>Indian J Endocrinol Metab</i>. <b>16</b>: 67\u201371. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4103/2230-8210.91193\">10.4103/2230-8210.91193</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263199\">3263199</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22276254\">22276254</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Indian+J+Endocrinol+Metab&amp;rft.atitle=Metabolic+syndrome+in+the+Middle+East&amp;rft.volume=16&amp;rft.pages=67-71&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263199&amp;rft_id=info%3Apmid%2F22276254&amp;rft_id=info%3Adoi%2F10.4103%2F2230-8210.91193&amp;rft.aulast=Sliem&amp;rft.aufirst=HA&amp;rft.au=Ahmed%2C+S&amp;rft.au=Nemr%2C+N&amp;rft.au=El-Sherif%2C+I&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3263199&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-NAC_37-18\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NAC_37_18-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NAC_37_18-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 North America and Caribbean.\" IDF NAC - Diabetes Update Fact Sheet. International Diabetes Federation - IDF NAC, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_NAC_5E_Update_FactSheet.pdf\">http://www.idf.org/sites/default/files/IDF_NAC_5E_Update_FactSheet.pdf</a>&gt;.</span>\n</li>\n<li id=\"cite_note-MS_Caribbean_38-19\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-MS_Caribbean_38_19-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-MS_Caribbean_38_19-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-MS_Caribbean_38_19-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tull ES, Thurland A, LaPorte RE (2005). \"Metabolic syndrome among Caribbean-born persons living in the U.S. Virgin Islands\". <i>Rev. Panam. Salud Publica</i>. <b>18</b>: 418\u201326. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1590/s1020-49892005001000005\">10.1590/s1020-49892005001000005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16536928\">16536928</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Rev.+Panam.+Salud+Publica&amp;rft.atitle=Metabolic+syndrome+among+Caribbean-born+persons+living+in+the+U.S.+Virgin+Islands&amp;rft.volume=18&amp;rft.pages=418-26&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1590%2Fs1020-49892005001000005&amp;rft_id=info%3Apmid%2F16536928&amp;rft.aulast=Tull&amp;rft.aufirst=ES&amp;rft.au=Thurland%2C+A&amp;rft.au=LaPorte%2C+RE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-CDC-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-CDC_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-CDC_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-CDC_20-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-CDC_20-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\">Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. Available at <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov\">https://www.cdc.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-Boyle-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Boyle_21-0\">^</a></b></span> <span class=\"reference-text\">Boyle JP et al. Projection of the year 2050 burden of diabetes in the U.S. adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8:1-12.</span>\n</li>\n<li id=\"cite_note-Mayo-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mayo_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mayo_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Mayo Clinic. Prediabetes. Available at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.mayoclinic.com\">http://www.mayoclinic.com</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-NIDDKD-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NIDDKD_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NIDDKD_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">National Institute of Diabetes and Digestive and Kidney Diseases. Insulin resistance and pre-diabetes. Available at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.diabetes.niddk.nih.gov\">http://www.diabetes.niddk.nih.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-DeFronzo-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-DeFronzo_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-DeFronzo_24-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">DeFronzo RA and Abdul-Ghani M. \"Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. <i>Am J Cardiol.</i> 2011;108 (3 Suppl): 3B-24B.</span>\n</li>\n<li id=\"cite_note-Pour-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Pour_25-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pour OR, Dagogo-Jack S (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4395135\">\"Prediabetes as a therapeutic target\"</a>. <i>Clin. Chem</i>. <b>57</b>: 215\u2013220. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1373/clinchem.2010.149096\">10.1373/clinchem.2010.149096</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4395135\">4395135</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Chem.&amp;rft.atitle=Prediabetes+as+a+therapeutic+target&amp;rft.volume=57&amp;rft.pages=215-220&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4395135&amp;rft_id=info%3Adoi%2F10.1373%2Fclinchem.2010.149096&amp;rft.aulast=Pour&amp;rft.aufirst=OR&amp;rft.au=Dagogo-Jack%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4395135&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ford_Pre-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ford_Pre_26-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ford ES;  et al. (2010). \"Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence\". <i>J Am Coll Cardiol</i>. <b>55</b>: 1310\u20131317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jacc.2009.10.060\">10.1016/j.jacc.2009.10.060</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Am+Coll+Cardiol&amp;rft.atitle=Pre-diabetes+and+the+risk+for+cardiovascular+disease%3A+a+systematic+review+of+the+evidence&amp;rft.volume=55&amp;rft.pages=1310-1317&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jacc.2009.10.060&amp;rft.au=Ford+ES&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TOS-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TOS_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TOS_27-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">The Obesity Society. Your weight and diabetes. Available at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.obesity.org\">http://www.obesity.org</a>. Accessed November 9, 2012</span>\n</li>\n<li id=\"cite_note-ADA_Dia_Bas-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ADA_Dia_Bas_28-0\">^</a></b></span> <span class=\"reference-text\">American Diabetes Association. Diabetes basics. Available at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.diabetes.org/about-diabetes.jsp\">http://www.diabetes.org/about-diabetes.jsp</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-WHOO&amp;O-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-WHOO&amp;O_29-0\">^</a></b></span> <span class=\"reference-text\">World Health Organization. Obesity and overweight. Available at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.who.int\">http://www.who.int</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-CDCO&amp;O-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-CDCO&amp;O_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-CDCO&amp;O_30-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">Centers for Disease Control and Prevention. Overweight and obesity. Available at <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov\">https://www.cdc.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-Roger_VL-31\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Roger_VL_31-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-Roger_VL_31-12\"><sup><i><b>m</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Roger VL;  et al. (2012). \"Heart disease and stroke statistics\u20142012 update: a report from the American Heart Association\". <i>Circulation</i>. <b>125</b>: e2\u2013e220. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/cir.0b013e31823ac046\">10.1161/cir.0b013e31823ac046</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Heart+disease+and+stroke+statistics%E2%80%942012+update%3A+a+report+from+the+American+Heart+Association&amp;rft.volume=125&amp;rft.pages=e2-e220&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1161%2Fcir.0b013e31823ac046&amp;rft.au=Roger+VL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Yoon-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Yoon_32-0\">^</a></b></span> <span class=\"reference-text\">Yoon SS et al. Hypertension among adults in the United States, 2009-2010. NCHS Data Brief. 2012;82:1-8.</span>\n</li>\n<li id=\"cite_note-CDCP_CFS-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CDCP_CFS_33-0\">^</a></b></span> <span class=\"reference-text\">Centers for Disease Control and Prevention. Cholesterol: facts and statistics. Available at <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov\">https://www.cdc.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-Cohen_JD_25-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cohen_JD_25_34-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cohen JD;  et al. (2010). \"30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006\". <i>Am J Cardiol</i>. <b>106</b>: 969\u2013975. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjcard.2010.05.030\">10.1016/j.amjcard.2010.05.030</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+J+Cardiol&amp;rft.atitle=30-year+trends+in+serum+lipids+among+United+States+adults%3A+results+from+the+National+Health+and+Nutrition+Examination+Surveys+II%2C+III%2C+and+1999-2006&amp;rft.volume=106&amp;rft.pages=969-975&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjcard.2010.05.030&amp;rft.au=Cohen+JD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-ADADD_26-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-ADADD_26_35-0\">^</a></b></span> <span class=\"reference-text\">American Diabetes Association. Diabetic dyslipidemia. Diabetes &amp; Cardiovascular Disease Review. 2006;3:1-4.</span>\n</li>\n<li id=\"cite_note-Schubert_27-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Schubert_27_36-0\">^</a></b></span> <span class=\"reference-text\">Schubert CM et al. Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. <i>J Pediatr.</i> 2009; 155(Suppl):S1-S7.</span>\n</li>\n<li id=\"cite_note-CDC_28-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-CDC_28_37-0\">^</a></b></span> <span class=\"reference-text\">Centers for Disease Control and Prevention. Prevalence of obesity among children and adolescents: United States, trends 1963-1965 through 2007-2008. Available at <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov\">https://www.cdc.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-CDC_29-38\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-CDC_29_38-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-CDC_29_38-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-CDC_29_38-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Centers for Disease Control and Prevention. Children and diabetes: SEARCH for diabetes in youth. Available at <a rel=\"nofollow\" class=\"external free\" href=\"https://www.cdc.gov\">https://www.cdc.gov</a>. Accessed November 9, 2012.</span>\n</li>\n<li id=\"cite_note-NCEP_39-39\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NCEP_39_39-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-NCEP_39_39-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\">Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Rep. N.p.: NIH, 2002. 02-5215. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Sept. 2002. Web. 29 Nov. 2012. &lt;<cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20081001162251/http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf\">\"Archived copy\"</a> <span style=\"font-size:85%;\">(PDF)</span>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf\">the original</a> <span style=\"font-size:85%;\">(PDF)</span> on 2008-10-01<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2008-10-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.nhlbi.nih.gov%2Fguidelines%2Fcholesterol%2Fatp3full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span>&gt;.</span>\n</li>\n<li id=\"cite_note-SACA_40-40\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SACA_40_40-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SACA_40_40-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SACA_40_40-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 South and Central America.\" IDF SACA - Diabetes Update Fact Sheet. International Diabetes Federation - IDF SACA, n.d. Web. 30 Nov. 2012. &lt; <a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_SACA_5E_Update_FactSheet.pdf\">http://www.idf.org/sites/default/files/IDF_SACA_5E_Update_FactSheet.pdf</a> &gt;.</span>\n</li>\n<li id=\"cite_note-EMSLA_41-41\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-EMSLA_41_41-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-EMSLA_41_41-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cuevas A, Alvarez V, Carrasco F (2011). \"Epidemic of metabolic syndrome in Latin America\". <i>Curr Opin Endocrinol Diabetes Obes</i>. <b>18</b>: 134\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1097/MED.0b013e3283449167\">10.1097/MED.0b013e3283449167</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21358406\">21358406</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr+Opin+Endocrinol+Diabetes+Obes&amp;rft.atitle=Epidemic+of+metabolic+syndrome+in+Latin+America&amp;rft.volume=18&amp;rft.pages=134-8&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1097%2FMED.0b013e3283449167&amp;rft_id=info%3Apmid%2F21358406&amp;rft.aulast=Cuevas&amp;rft.aufirst=A&amp;rft.au=Alvarez%2C+V&amp;rft.au=Carrasco%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-EHSA_42-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-EHSA_42_42-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pramparo P (2002). \"The epidemiology of hypertension in South America\". <i>J Hum Hypertens</i>. 16 Suppl 1: S3\u20136. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/sj.jhh.1001331\">10.1038/sj.jhh.1001331</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11986883\">11986883</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Hum+Hypertens&amp;rft.atitle=The+epidemiology+of+hypertension+in+South+America&amp;rft.volume=16+Suppl+1&amp;rft.pages=S3-6&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.jhh.1001331&amp;rft_id=info%3Apmid%2F11986883&amp;rft.au=Pramparo+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEpidemiology+of+metabolic+syndrome\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-SEA_43-43\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-SEA_43_43-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-SEA_43_43-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-SEA_43_43-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 South-East Asia.\" IDF SEA - Diabetes Update Fact Sheet. International Diabetes Federation - IDF SEA, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_SEA_5E_Update_FactSheet.pdf\">http://www.idf.org/sites/default/files/IDF_SEA_5E_Update_FactSheet.pdf</a> &gt;.</span>\n</li>\n<li id=\"cite_note-WP_44-44\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-WP_44_44-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-WP_44_44-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\">\"Diabetes at a Glance, 2012 Western Pacific.\" IDF WP - Diabetes Update Fact Sheet. International Diabetes Federation - IDF WP, n.d. Web. 30 Nov. 2012. &lt;<a rel=\"nofollow\" class=\"external free\" href=\"http://www.idf.org/sites/default/files/IDF_WP_5E_Update_FactSheet.pdf\">http://www.idf.org/sites/default/files/IDF_WP_5E_Update_FactSheet.pdf</a>&gt;.</span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw2230\nCached time: 20180915065025\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.304 seconds\nReal time usage: 0.328 seconds\nPreprocessor visited node count: 1481/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 35942/2097152 bytes\nTemplate argument size: 98/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 52593/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.099/10.000 seconds\nLua memory usage: 3.2 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  254.238      1 -total\n 65.14%  165.609      1 Template:Reflist\n 42.10%  107.044     17 Template:Cite_journal\n  9.89%   25.155      1 Template:Main\n  1.98%    5.025      1 Template:Cite_web\n  1.00%    2.542      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:36738647-0!canonical and timestamp 20180915065024 and revision id 854164149\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"CS1_maint:_Explicit_use_of_et_al."},{"sortkey":"","*":"Diabetes"},{"sortkey":"","*":"Epidemiology"},{"sortkey":"","*":"Obesity"}],"links":[{"ns":0,"exists":"","*":"American Heart Association"},{"ns":0,"exists":"","*":"Angina"},{"ns":0,"exists":"","*":"Arthritis"},{"ns":0,"exists":"","*":"Blood glucose"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Cardiovascular disease"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"Central Europe"},{"ns":0,"exists":"","*":"Cholesterol"},{"ns":0,"exists":"","*":"Congestive heart failure"},{"ns":0,"exists":"","*":"Coronary artery disease"},{"ns":0,"exists":"","*":"Developing countries"},{"ns":0,"exists":"","*":"Diabetes"},{"ns":0,"exists":"","*":"Diastolic"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dyslipidemia"},{"ns":0,"exists":"","*":"HDL cholesterol"},{"ns":0,"exists":"","*":"Hypertension"},{"ns":0,"exists":"","*":"International Diabetes Federation"},{"ns":0,"exists":"","*":"Lagos, Nigeria"},{"ns":0,"exists":"","*":"Metabolic syndrome"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"National Heart, Lung, and Blood Institute"},{"ns":0,"exists":"","*":"Obesity"},{"ns":0,"exists":"","*":"Overweight"},{"ns":0,"exists":"","*":"Plasma glucose"},{"ns":0,"exists":"","*":"Prediabetes"},{"ns":0,"exists":"","*":"Prevalence"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Triglyceride"},{"ns":0,"exists":"","*":"Type 1 diabetes"},{"ns":0,"exists":"","*":"Type 2 diabetes"},{"ns":0,"exists":"","*":"Ventricular hypertrophy"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"*":"Coronary revascularization"},{"ns":0,"*":"Ischaemic attack"},{"ns":14,"exists":"","*":"Category:CS1 maint: Explicit use of et al."}],"templates":[{"ns":10,"exists":"","*":"Template:Main"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Main"},{"ns":828,"exists":"","*":"Module:Hatnote"},{"ns":828,"exists":"","*":"Module:Hatnote list"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//doi.org/10.1111/j.1753-0407.2010.00078.x","//doi.org/10.2337/diacare.27.10.2444","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3005489","//doi.org/10.2337/dc10-0879","//www.ncbi.nlm.nih.gov/pubmed/20889854","//doi.org/10.1161/circulationaha.105.539528","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2597726","//doi.org/10.1016/j.ahj.2008.02.022","//doi.org/10.1016/j.amjcard.2008.03.037","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2518368","//doi.org/10.2337/dc08-0423","//www.ncbi.nlm.nih.gov/pubmed/18591398","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263198","//doi.org/10.4103/2230-8210.91191","//www.ncbi.nlm.nih.gov/pubmed/22276253","//doi.org/10.1038/jhh.2008.136","//www.ncbi.nlm.nih.gov/pubmed/19005476","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3263199","//doi.org/10.4103/2230-8210.91193","//www.ncbi.nlm.nih.gov/pubmed/22276254","//doi.org/10.1590/s1020-49892005001000005","//www.ncbi.nlm.nih.gov/pubmed/16536928","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4395135","//doi.org/10.1373/clinchem.2010.149096","//doi.org/10.1016/j.jacc.2009.10.060","//doi.org/10.1161/cir.0b013e31823ac046","//doi.org/10.1016/j.amjcard.2010.05.030","https://web.archive.org/web/20081001162251/http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf","http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf","//doi.org/10.1097/MED.0b013e3283449167","//www.ncbi.nlm.nih.gov/pubmed/21358406","//doi.org/10.1038/sj.jhh.1001331","//www.ncbi.nlm.nih.gov/pubmed/11986883","http://www.who.int/mediacentre/factsheets/fs311/en/","http://www.idf.org/diabetesatlas/5e/the-global-burden","http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf","http://www.idf.org/sites/default/files/IDF_AFR_5E_Update_FactSheet_0.pdf","http://www.voanews.com/content/diabetes-sub-saharan-africa-africa-hopeclinic-projecthope/1554338.html","http://www.idf.org/sites/default/files/IDF_EUR_5E_Update_FactSheet1_0.pdf","http://www.idf.org/sites/default/files/IDF_MENA_5E_Update_FactSheet.pdf","http://www.idf.org/sites/default/files/IDF_NAC_5E_Update_FactSheet.pdf","https://www.cdc.gov","http://www.mayoclinic.com","http://www.diabetes.niddk.nih.gov","http://www.obesity.org","http://www.diabetes.org/about-diabetes.jsp","http://www.who.int","http://www.idf.org/sites/default/files/IDF_SACA_5E_Update_FactSheet.pdf","http://www.idf.org/sites/default/files/IDF_SEA_5E_Update_FactSheet.pdf","http://www.idf.org/sites/default/files/IDF_WP_5E_Update_FactSheet.pdf"],"sections":[{"toclevel":1,"level":"2","line":"Background","number":"1","index":"1","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":2087,"anchor":"Background"},{"toclevel":1,"level":"2","line":"Africa","number":"2","index":"2","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":5609,"anchor":"Africa"},{"toclevel":1,"level":"2","line":"Europe","number":"3","index":"3","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":8020,"anchor":"Europe"},{"toclevel":1,"level":"2","line":"Middle East and North Africa","number":"4","index":"4","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":11193,"anchor":"Middle_East_and_North_Africa"},{"toclevel":1,"level":"2","line":"North America and the Caribbean","number":"5","index":"5","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":13478,"anchor":"North_America_and_the_Caribbean"},{"toclevel":2,"level":"3","line":"United States","number":"5.1","index":"6","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":15265,"anchor":"United_States"},{"toclevel":2,"level":"3","line":"United states children","number":"5.2","index":"7","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":22452,"anchor":"United_states_children"},{"toclevel":2,"level":"3","line":"Native Americans (American Indians)","number":"5.3","index":"8","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":25660,"anchor":"Native_Americans_(American_Indians)"},{"toclevel":1,"level":"2","line":"South and Central America","number":"6","index":"9","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":27582,"anchor":"South_and_Central_America"},{"toclevel":1,"level":"2","line":"South-East Asia","number":"7","index":"10","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":29998,"anchor":"South-East_Asia"},{"toclevel":1,"level":"2","line":"Western Pacific","number":"8","index":"11","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":31493,"anchor":"Western_Pacific"},{"toclevel":1,"level":"2","line":"References","number":"9","index":"12","fromtitle":"Epidemiology_of_metabolic_syndrome","byteoffset":32718,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Epidemiology of metabolic syndrome","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q22908189"}]}}